PharPoint Research, Inc.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Durham NC United States (2007)

Organization Overview

First Clinical Trial
2016
NCT02702778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

PharPoint Research, Inc.